Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Micropapillary bladder cancer: Current treatment patterns and review of the literature.

Willis DL, Flaig TW, Hansel DE, Milowsky MI, Grubb RL, Al-Ahmadie HA, Plimack ER, Koppie TM, McConkey DJ, Dinney CP, Hoffman VA, Droller MJ, Messing E, Kamat AM.

Urol Oncol. 2014 Jun 12. pii: S1078-1439(14)00026-X. doi: 10.1016/j.urolonc.2014.01.020. [Epub ahead of print]

PMID:
24931270
[PubMed - as supplied by publisher]
2.

Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.

Paner GP, Annaiah C, Gulmann C, Rao P, Ro JY, Hansel DE, Shen SS, Lopez-Beltran A, Aron M, Luthringer DJ, De Peralta-Venturina M, Cho Y, Amin MB.

Hum Pathol. 2014 Jul;45(7):1473-82. doi: 10.1016/j.humpath.2014.02.024. Epub 2014 Mar 14.

PMID:
24780825
[PubMed - in process]
3.

Highlights from the first symposium on upper tract urothelial carcinoma.

Matin SF, Shariat SF, Milowsky MI, Hansel DE, Kassouf W, Koppie T, Bajorin D, Grollman AP.

Urol Oncol. 2014 Apr;32(3):309-16. doi: 10.1016/j.urolonc.2013.08.029. Epub 2014 Jan 4.

PMID:
24397995
[PubMed - in process]
4.

Uroplakin II outperforms uroplakin III in diagnostically challenging settings.

Smith SC, Mohanty SK, Kunju LP, Chang E, Chung F, Carvalho JC, Paner GP, Hansel DE, Luthringer DJ, de Peralta-Ventrurina MN, Amin MB.

Histopathology. 2014 Jul;65(1):132-8. doi: 10.1111/his.12360. Epub 2014 Feb 25.

PMID:
24382161
[PubMed - in process]
5.

Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion.

Gupta S, Hau AM, Beach JR, Harwalker J, Mantuano E, Gonias SL, Egelhoff TT, Hansel DE.

PLoS One. 2013 Nov 27;8(11):e81081. doi: 10.1371/journal.pone.0081081. eCollection 2013.

PMID:
24312263
[PubMed - in process]
Free PMC Article
6.

Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia.

Aron M, Luthringer DJ, McKenney JK, Hansel DE, Westfall DE, Parakh R, Mohanty SK, Balzer B, Amin MB.

Am J Surg Pathol. 2013 Dec;37(12):1815-23. doi: 10.1097/PAS.0000000000000114.

PMID:
24225842
[PubMed - indexed for MEDLINE]
7.

Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologists.

Ananthanarayanan V, Pan Y, Tretiakova M, Amin MB, Cheng L, Epstein JI, Grignon DJ, Hansel DE, Jimenez RE, McKenney JK, Montironi R, Oliva E, Osunkoya AO, Rao P, Reuter VE, Ro JY, Shen SS, Srigley JR, Tsuzuki T, Yao JL, Antic T, Haber M, Taxy JB, Paner GP.

Am J Surg Pathol. 2014 Feb;38(2):167-75. doi: 10.1097/PAS.0000000000000096.

PMID:
24145655
[PubMed - indexed for MEDLINE]
8.

Gene profiling suggests a common evolution of bladder cancer subtypes.

Hansel DE, Zhang Z, Petillo D, Teh BT.

BMC Med Genomics. 2013 Oct 17;6:42. doi: 10.1186/1755-8794-6-42.

PMID:
24134934
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Diagnostically challenging cases: what are atypia and dysplasia?

Sanfrancesco J, Jones JS, Hansel DE.

Urol Clin North Am. 2013 May;40(2):281-93. doi: 10.1016/j.ucl.2013.01.006. Epub 2013 Feb 26.

PMID:
23540785
[PubMed - indexed for MEDLINE]
10.

Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist.

Hansel DE, Miller JS, Cookson MS, Chang SS.

Urology. 2013 Jun;81(6):1123-30. doi: 10.1016/j.urology.2013.01.027. Epub 2013 Mar 19. Review.

PMID:
23522296
[PubMed - indexed for MEDLINE]
11.

Editorial comment.

Hansel DE.

J Urol. 2013 May;189(5):1660-1. doi: 10.1016/j.juro.2012.11.194. Epub 2013 Feb 16. No abstract available.

PMID:
23419938
[PubMed - indexed for MEDLINE]
12.

The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo.

Zhou N, Singh K, Mir MC, Parker Y, Lindner D, Dreicer R, Ecsedy JA, Zhang Z, Teh BT, Almasan A, Hansel DE.

Clin Cancer Res. 2013 Apr 1;19(7):1717-28. doi: 10.1158/1078-0432.CCR-12-2383. Epub 2013 Feb 12.

PMID:
23403633
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma.

Patel AR, Cohn JA, Abd El Latif A, Miocinovic R, Steinberg GD, Paner GP, Hansel DE.

J Urol. 2013 Jan;189(1):53-8. doi: 10.1016/j.juro.2012.09.006. Epub 2012 Nov 16.

PMID:
23164389
[PubMed - indexed for MEDLINE]
14.

Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.

Gruver AM, Amin MB, Luthringer DJ, Westfall D, Arora K, Farver CF, Osunkoya AO, McKenney JK, Hansel DE.

Arch Pathol Lab Med. 2012 Nov;136(11):1339-46. doi: 10.5858/arpa.2011-0575-OA.

PMID:
23106579
[PubMed - indexed for MEDLINE]
15.

A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens.

Hansel DE, Amin MB, Comperat E, Cote RJ, Knüchel R, Montironi R, Reuter VE, Soloway MS, Umar SA, Van der Kwast TH.

Eur Urol. 2013 Feb;63(2):321-32. doi: 10.1016/j.eururo.2012.10.008. Epub 2012 Oct 12. Review.

PMID:
23088996
[PubMed - indexed for MEDLINE]
16.

The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy.

Abd El-Latif A, Watts KE, Elson P, Fergany A, Hansel DE.

J Urol. 2013 Apr;189(4):1263-7. doi: 10.1016/j.juro.2012.10.054. Epub 2012 Oct 17.

PMID:
23085297
[PubMed - indexed for MEDLINE]
17.

ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology.

Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, Lin O, Jorda M, Jenkins LC, Soloway M, Epstein JI, Reuter VE; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.

Eur Urol. 2013 Jan;63(1):16-35. doi: 10.1016/j.eururo.2012.09.063. Epub 2012 Oct 5. Review.

PMID:
23083804
[PubMed - indexed for MEDLINE]
18.

Small cell bladder cancer: biology and management.

Fahed E, Hansel DE, Raghavan D, Quinn DI, Dorff TB.

Semin Oncol. 2012 Oct;39(5):615-8. doi: 10.1053/j.seminoncol.2012.08.009. Review.

PMID:
23040258
[PubMed - indexed for MEDLINE]
19.

Prognostic value of cell-cycle regulation biomarkers in bladder cancer.

Mitra AP, Hansel DE, Cote RJ.

Semin Oncol. 2012 Oct;39(5):524-33. doi: 10.1053/j.seminoncol.2012.08.008. Review.

PMID:
23040249
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract.

Gulmann C, Paner GP, Parakh RS, Hansel DE, Shen SS, Ro JY, Annaiah C, Lopez-Beltran A, Rao P, Arora K, Cho Y, Herrera-Hernandez L, Alsabeh R, Amin MB.

Hum Pathol. 2013 Feb;44(2):164-72. doi: 10.1016/j.humpath.2012.05.018. Epub 2012 Sep 17.

PMID:
22995333
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk